You are here: Industry Insights > Milestone

News List

Milestone Enrolls First Patient in ReVeRA Study for Etripamil for Atrial Fibrillation americanpharmaceuticalreview
April 02, 2021
Milestone Pharmaceuticals announced the first patient has been enrolled in its Phase 2 proof-of-concept study of etripamil nasal spray for the Reduction of Ventricular Rate in patients experiencing Atrial fibrillation and rapid ventricular rate ...
Publication of a Toxicological Study: A Milestone for Jennewein Biotechnologie for the GRAS Approval of the HMO-mix prnasia
January 09, 2020
After the EU Novel Food Dossier was submitted to the European Commission in August 2019, the way is now clear for the GRAS (General Regarded As Safe) decision at the US FDA (Food and Drug Administration).
Emendo Biotherapeutics Achieves Takeda Milestone contractpharma
August 21, 2019
Funds will be used to further advance Emendo's nuclease discovery platform and portfolio development programs.
ProBioGen Announces Further Development Milestone for Use of Its GlymaxX® Cancer Cell-Killing Enhancement Antibody Technology with Merus N.V. b3cnewswire.
June 04, 2018
ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announced that the company achieved an undisclosed milestone payment from Merus N.V. (NASDAQ: MRUS) based on Merus’ use of MCLA-158
Novo Nordisk achieves milestone in stem cell-based therapies financialexpress
May 21, 2018
Novo Nordisk has recently announced an increased commitment to stem cell-based therapies and an expansion of the focus on type 1 diabetes into other serious chronic diseases.
ViiV reaches another milestone in the development of a long-acting HIV regimen pharmaceutical-technology
July 31, 2017
On July 24, 2017, ViiV Healthcare announced positive results from 96-week data obtained from a Phase IIb, open-label study (LATTE-2) investigating the safety and efficacy of a two-drug...
Milestone Pharmaceuticals Announces Etripamil Phase 2 Clinical Program Success americanpharmaceuticalreview
May 15, 2017
Milestone Pharmaceuticals announced positive data from its Phase 2 NODE-1 trial evaluating etripamil, for the acute treatment of patients with paroxysmal supraventricular tachycardia (PSVT), a potentially debilitating cardiac arrhythmia.
AstraZeneca marks a key milestone with the ‘topping out’ of new global R&D centre and HQ in Cambridg worldpharmanews
May 03, 2017
AstraZeneca marks a key milestone in its successful move to Cambridge, UK, with the 'topping out' of its new, state-of-the-art, strategic R&D centre and global corporate headquarters at the heart of the Cambridge Biomedical Campus (CBC).
Heptares Gets $12mn AstraZeneca Milestone contractpharma
April 11, 2017
Heptares Therapeutics has achieved an important milestone in its immuno-oncology collaboration with AstraZeneca, which is focused on the development of AZD4635 (HTL-1071) as a potential new treatment for a range of cancers.
Hemispherx Meets Ampligen Milestone contractpharma
March 07, 2017
Initiates accelerated production plan with its contract manufacturers to meet future demand

Previous page 1 2 Next page